Core Scientific (NASDAQ:CORZ) Given New $20.00 Price Target at Canaccord Genuity Group

Core Scientific (NASDAQ:CORZ) had its target price lifted by Canaccord Genuity Group from $17.00 to $20.00 in a research report sent to investors on Wednesday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

Other analysts have also recently issued research reports about the company. Cantor Fitzgerald lowered their price target on Core Scientific from $26.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday. Keefe, Bruyette & Woods boosted their target price on shares of Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a report on Tuesday, January 27th. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target for the company in a research report on Thursday, December 18th. BTIG Research raised shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Tuesday, January 6th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $24.84.

Core Scientific Stock Performance

CORZ stock opened at $15.84 on Wednesday. The company has a 50 day moving average price of $17.28 and a two-hundred day moving average price of $16.96. The stock has a market capitalization of $4.99 billion, a P/E ratio of 13.54 and a beta of 6.87. Core Scientific has a one year low of $6.20 and a one year high of $23.63.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings data on Monday, March 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.69. The business had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. Core Scientific’s revenue for the quarter was down 16.0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.69) EPS. Research analysts forecast that Core Scientific will post 0.52 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Core Scientific

Several institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC grew its stake in shares of Core Scientific by 106.1% in the first quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock valued at $2,052,000 after buying an additional 145,905 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Core Scientific by 180.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock worth $8,032,000 after acquiring an additional 714,388 shares during the period. Nisa Investment Advisors LLC grew its position in Core Scientific by 192.3% in the second quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock valued at $80,000 after acquiring an additional 3,067 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of Core Scientific by 31.4% during the second quarter. Teacher Retirement System of Texas now owns 42,543 shares of the company’s stock valued at $726,000 after purchasing an additional 10,161 shares during the period. Finally, Amalgamated Bank lifted its position in shares of Core Scientific by 52.2% during the second quarter. Amalgamated Bank now owns 9,423 shares of the company’s stock worth $161,000 after purchasing an additional 3,231 shares in the last quarter.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Multiple analyst upgrades/raises reinforce bullish expectations — Canaccord raised its target to $20 and kept a Buy rating, Needham upgraded to Buy with a $23 target, and HC Wainwright reaffirmed Buy at $25, signaling institutional conviction in the AI pivot and creating upside narrative for the stock. Canaccord Raise
• Positive Sentiment: Colocation (AI) revenue is accelerating — company reports show colocation revenue surged ~268% YoY, driven by contracts such as CoreWeave; that growth supports the strategic shift from Bitcoin mining toward higher-margin AI services. Colocation Revenue Surge
• Positive Sentiment: CoreWeave deal progressing ahead of schedule — management commentary and press pieces note the CoreWeave relationship is on track, supporting near-term colocation revenue visibility. CoreWeave Ahead of Schedule
• Positive Sentiment: Large call-option activity suggests speculative/bullish positioning — unusually high call volume (≈188,642 calls) indicates investors are placing leveraged bullish bets ahead of anticipated upside from the AI pivot.
• Neutral Sentiment: MarketBeat / analysis pieces argue a long-term, multi-billion backlog tied to AI colocation could unlock large upside, but these are thesis pieces rather than new company disclosures; useful for framing upside but dependent on execution. MarketBeat AI Thesis
• Neutral Sentiment: Short-interest entries in the feed show anomalous/zero values (likely reporting noise) and do not provide actionable short-seller signal at this time.
• Negative Sentiment: Top-line weakness and volatility in earnings — Q4 results showed a sharp revenue decline (reports cite ~38% YoY drop) and a revenue miss versus consensus, and management flagged negative adjusted EBITDA tied to the transition/expansion which pressured sentiment and drove intraday weakness after the release. Q4 Revenue Fall
• Negative Sentiment: Near-term sell-side caution and price action — media and market coverage noted a material stock pullback (one headline cited a ~14% drop after the pivot/earnings), reflecting investor concern about execution risk, cash burn for expansion, and balance-sheet pressure. Stock Drop After Pivot

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.